FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211014785> ?p ?o ?g. }

• W4211014785 abstract "Abstract OBJECTIVES The comparative effectiveness and safety of proton pump inhibitors (PPIs) versus histamine-2 receptor blockers for stress ulcer prophylaxis in the cardiac surgical intensive care unit population is uncertain. Although the Proton Pump Inhibitors versus Histamine-2 Receptor Blockers for Ulcer Prophylaxis Therapy in the Intensive Care Unit (PEPTIC) trial reported a higher risk of mortality in the PPI arm with no difference in gastrointestinal bleeding, detailed information on surgical variables and clinically relevant surgical subgroups was not available. METHODS The analysis included all Canadian cardiac surgery patients enrolled in the PEPTIC trial. Data were electronically linked using unique patient identifiers to a clinical information system. Outcomes of interest included in-hospital mortality, gastrointestinal bleeding, Clostridium difficile infections, ventilator-associated conditions and length of stay. RESULTS We studied 823 (50.6%) randomized to PPIs and 805 (49.4%) to histamine-2-receptor blockers. In the intention-to-treat analysis, there were no differences in hospital mortality [PPI: 4.3% vs histamine-2 receptor blockers: 4.8%, adjusted odds ratio (aOR) 0.97, 95% confidence interval (CI) 0.55–1.70], gastrointestinal bleeding (3.9% vs 4.8%, aOR 1.09, 95% CI 0.66–1.81), C. difficile infections (0.9% vs 0.1%, aOR 0.18, 95% CI 0.02–1.59), ventilator-associated conditions (1.6% vs 1.7%, aOR 0.92, 95% CI 0.85–1.00) or median length of stay (9.2 vs 9.8 days, adjusted risk ratio 1.06, 85% CI 0.99–1.13). No significant treatment differences were observed among subgroups of interest or per-protocol populations. CONCLUSIONS In a secondary analysis of cardiac surgery patients enrolled in the PEPTIC trial in Canada, no differences in effectiveness or safety were observed between use of PPIs and histamine-2 receptor blockers for stress ulcer prophylaxis. Clinical trial registration number anzctr.org.au identifier: ACTRN12616000481471." @default.
• W4211014785 created "2022-02-13" @default.
• W4211014785 creator A5005333139 @default.
• W4211014785 creator A5007249471 @default.
• W4211014785 creator A5009851760 @default.
• W4211014785 creator A5016206619 @default.
• W4211014785 creator A5022893633 @default.
• W4211014785 creator A5035284329 @default.
• W4211014785 creator A5036301763 @default.
• W4211014785 creator A5037332893 @default.
• W4211014785 creator A5038005820 @default.
• W4211014785 creator A5057325715 @default.
• W4211014785 creator A5068301444 @default.
• W4211014785 creator A5071775590 @default.
• W4211014785 date "2022-02-25" @default.
• W4211014785 modified "2023-09-27" @default.
• W4211014785 title "Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial" @default.
• W4211014785 cites W1567680096 @default.
• W4211014785 cites W1993679832 @default.
• W4211014785 cites W2024258692 @default.
• W4211014785 cites W2038043605 @default.
• W4211014785 cites W2082169659 @default.
• W4211014785 cites W2116612251 @default.
• W4211014785 cites W2116770308 @default.
• W4211014785 cites W2125756825 @default.
• W4211014785 cites W2145799252 @default.
• W4211014785 cites W2152376036 @default.
• W4211014785 cites W2160961074 @default.
• W4211014785 cites W2166660180 @default.
• W4211014785 cites W2276451718 @default.
• W4211014785 cites W2282336375 @default.
• W4211014785 cites W2313397377 @default.
• W4211014785 cites W2316130350 @default.
• W4211014785 cites W2319207481 @default.
• W4211014785 cites W2587799477 @default.
• W4211014785 cites W2604659934 @default.
• W4211014785 cites W2774163295 @default.
• W4211014785 cites W2811131397 @default.
• W4211014785 cites W2884934935 @default.
• W4211014785 cites W2898389841 @default.
• W4211014785 cites W2898405148 @default.
• W4211014785 cites W2943204414 @default.
• W4211014785 cites W2982316804 @default.
• W4211014785 cites W2999734656 @default.
• W4211014785 cites W3131100411 @default.
• W4211014785 cites W58879651 @default.
• W4211014785 doi "https://doi.org/10.1093/ejcts/ezac124" @default.
• W4211014785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35213716" @default.
• W4211014785 hasPublicationYear "2022" @default.
• W4211014785 type Work @default.
• W4211014785 citedByCount "1" @default.
• W4211014785 countsByYear W42110147852022 @default.
• W4211014785 crossrefType "journal-article" @default.
• W4211014785 hasAuthorship W4211014785A5005333139 @default.
• W4211014785 hasAuthorship W4211014785A5007249471 @default.
• W4211014785 hasAuthorship W4211014785A5009851760 @default.
• W4211014785 hasAuthorship W4211014785A5016206619 @default.
• W4211014785 hasAuthorship W4211014785A5022893633 @default.
• W4211014785 hasAuthorship W4211014785A5035284329 @default.
• W4211014785 hasAuthorship W4211014785A5036301763 @default.
• W4211014785 hasAuthorship W4211014785A5037332893 @default.
• W4211014785 hasAuthorship W4211014785A5038005820 @default.
• W4211014785 hasAuthorship W4211014785A5057325715 @default.
• W4211014785 hasAuthorship W4211014785A5068301444 @default.
• W4211014785 hasAuthorship W4211014785A5071775590 @default.
• W4211014785 hasBestOaLocation W42110147851 @default.
• W4211014785 hasConcept C126322002 @default.
• W4211014785 hasConcept C156957248 @default.
• W4211014785 hasConcept C168563851 @default.
• W4211014785 hasConcept C2776345487 @default.
• W4211014785 hasConcept C2776376669 @default.
• W4211014785 hasConcept C2778080469 @default.
• W4211014785 hasConcept C2778451229 @default.
• W4211014785 hasConcept C2778789114 @default.
• W4211014785 hasConcept C2779390736 @default.
• W4211014785 hasConcept C2780656511 @default.
• W4211014785 hasConcept C2908647359 @default.
• W4211014785 hasConcept C42219234 @default.
• W4211014785 hasConcept C44249647 @default.
• W4211014785 hasConcept C71924100 @default.
• W4211014785 hasConcept C90924648 @default.
• W4211014785 hasConcept C99454951 @default.
• W4211014785 hasConceptScore W4211014785C126322002 @default.
• W4211014785 hasConceptScore W4211014785C156957248 @default.
• W4211014785 hasConceptScore W4211014785C168563851 @default.
• W4211014785 hasConceptScore W4211014785C2776345487 @default.
• W4211014785 hasConceptScore W4211014785C2776376669 @default.
• W4211014785 hasConceptScore W4211014785C2778080469 @default.
• W4211014785 hasConceptScore W4211014785C2778451229 @default.
• W4211014785 hasConceptScore W4211014785C2778789114 @default.
• W4211014785 hasConceptScore W4211014785C2779390736 @default.
• W4211014785 hasConceptScore W4211014785C2780656511 @default.
• W4211014785 hasConceptScore W4211014785C2908647359 @default.
• W4211014785 hasConceptScore W4211014785C42219234 @default.
• W4211014785 hasConceptScore W4211014785C44249647 @default.
• W4211014785 hasConceptScore W4211014785C71924100 @default.
• W4211014785 hasConceptScore W4211014785C90924648 @default.
• W4211014785 hasConceptScore W4211014785C99454951 @default.
• W4211014785 hasFunder F4320319990 @default.
• W4211014785 hasFunder F4320334506 @default.

• next